• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《2001年亚洲糖尿病护理——韩国结局数据与分析国家报告》

Diabcare Asia 2001--Korea country report on outcome data and analysis.

作者信息

Rhee Sang Youl, Kim Young Seol, Oh Seungjoon, Choi Woong Hwan, Park Jong Eun, Jeong Woo Jin

机构信息

Department of Endocrinology and Metabolism, School of Medicine, Kyung Hee University, Seoul, Korea.

出版信息

Korean J Intern Med. 2005 Mar;20(1):48-54. doi: 10.3904/kjim.2005.20.1.48.

DOI:10.3904/kjim.2005.20.1.48
PMID:15906953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3891412/
Abstract

BACKGROUND

The Diabcare-Asia study was designed for the purpose of describing diabetes control and management, and late complication status in the diabetic population.

METHODS

From the 1st of July 2001 to the 1st of September 2001, data from 1170 diabetic patients were collected in 21 centers (one university hospital and 20 clinics located in Seoul and in Gyeonggi, Korea), and blood samples were collected for centralized HbAtc measurements.

RESULTS

Only 16.8% of patients at the clinics reported self-monitoring their blood glucose. The mean HbA(1c) was 7.3 +/- 1.4% at the hospital and 7.5 +/- 1.5% at the clinics, and the mean fasting plasma glucose (FPG) levels were 7.0 +/- 3.3 mmol/L at the hospital and 7.9 +/- 2.5 mmol/L at the clinics. About 40% of patients had a HbA(1c) and FPG above the normal upper limits. Screening for microalbuminuria was rarely performed. The available data represents only about 0.9% of the patients at the hospital and 12.3% of the patients at the clinics. Nephropathy (serum creatinine >2 mg/dL) was found in 0.8% of the patients at the hospital and in 3.4% of the patients at the clinics. Retinopathy and neuropathy were commonly reported diabetic complications. The prevalence of other severe late complications was relatively low.

CONCLUSION

The data revealed suboptimal glycemic control in about 40% of patients.

摘要

背景

亚洲糖尿病护理研究旨在描述糖尿病患者的血糖控制与管理情况以及晚期并发症状况。

方法

2001年7月1日至2001年9月1日,在韩国首尔和京畿道的21个中心(1所大学医院和20家诊所)收集了1170例糖尿病患者的数据,并采集血样进行集中糖化血红蛋白(HbAtc)检测。

结果

诊所中仅16.8%的患者报告进行自我血糖监测。医院患者的糖化血红蛋白(HbA1c)均值为7.3±1.4%,诊所患者为7.5±1.5%;医院患者的空腹血糖(FPG)均值为7.0±3.3毫摩尔/升,诊所患者为7.9±2.5毫摩尔/升。约40%的患者糖化血红蛋白和空腹血糖高于正常上限。微量白蛋白尿筛查很少进行。现有数据仅代表医院约0.9%的患者和诊所12.3%的患者。医院0.8%的患者和诊所3.4%的患者发现患有肾病(血清肌酐>2毫克/分升)。视网膜病变和神经病变是常见的糖尿病并发症。其他严重晚期并发症的患病率相对较低。

结论

数据显示约40%的患者血糖控制欠佳。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7866/3891412/83b51496b67a/kjim-20-48-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7866/3891412/897e76709bd9/kjim-20-48-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7866/3891412/83b51496b67a/kjim-20-48-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7866/3891412/897e76709bd9/kjim-20-48-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7866/3891412/83b51496b67a/kjim-20-48-g002.jpg

相似文献

1
Diabcare Asia 2001--Korea country report on outcome data and analysis.《2001年亚洲糖尿病护理——韩国结局数据与分析国家报告》
Korean J Intern Med. 2005 Mar;20(1):48-54. doi: 10.3904/kjim.2005.20.1.48.
2
A window on the current status of diabetes mellitus in Singapore--the Diabcare-Singapore 1998 study.新加坡糖尿病现状之窗——1998年新加坡糖尿病护理研究
Singapore Med J. 2001 Nov;42(11):501-7.
3
Improvement of diabetic care at Maharat Nakhon Ratchasima Hospital (the study of Diabcare-Asia from 1997 to 2003).
J Med Assoc Thai. 2006 Jan;89(1):56-62.
4
Diabetes control and complications in public hospitals in Malaysia.马来西亚公立医院的糖尿病控制与并发症
Med J Malaysia. 2006 Oct;61(4):477-83.
5
Diabetes control and complications in private primary healthcare in Malaysia.马来西亚私立基层医疗中的糖尿病控制与并发症
Med J Malaysia. 2005 Jun;60(2):212-7.
6
The status of diabetes control in Malaysia: results of DiabCare 2008.马来西亚糖尿病控制状况:2008年糖尿病护理(DiabCare)结果
Med J Malaysia. 2011 Aug;66(3):175-81.
7
Current Management of Type 2 Diabetes Mellitus in Primary Care Clinics in Korea.韩国初级保健诊所中 2 型糖尿病的现行管理方法。
Endocrinol Metab (Seoul). 2019 Sep;34(3):282-290. doi: 10.3803/EnM.2019.34.3.282.
8
DiabCare survey of diabetes management and complications in the Gulf countries.海湾国家糖尿病管理与并发症的DiabCare调查。
Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):219-27. doi: 10.4103/2230-8210.176347.
9
Profile of Nigerians with diabetes mellitus - Diabcare Nigeria study group (2008): Results of a multicenter study.尼日利亚糖尿病患者概况 - 尼日利亚糖尿病关怀研究小组(2008年):一项多中心研究的结果
Indian J Endocrinol Metab. 2012 Jul;16(4):558-64. doi: 10.4103/2230-8210.98011.
10
Prevalence of diabetes mellitus and its complications in a population-based sample in Al Ain, United Arab Emirates.阿拉伯联合酋长国艾因市基于人群样本的糖尿病及其并发症患病率
Diabetes Res Clin Pract. 2007 Dec;78(3):369-77. doi: 10.1016/j.diabres.2007.04.008. Epub 2007 May 25.

引用本文的文献

1
Dietary glutamic acid and aspartic acid as biomarkers for predicting diabetic retinopathy.膳食谷氨酸和天冬氨酸作为预测糖尿病视网膜病变的生物标志物。
Sci Rep. 2021 Mar 31;11(1):7244. doi: 10.1038/s41598-021-83165-5.
2
Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy.血浆谷氨酰胺和谷氨酸是预测糖尿病视网膜病变的潜在生物标志物。
Metabolomics. 2018;14(7):89. doi: 10.1007/s11306-018-1383-3. Epub 2018 Jun 21.
3
Features of Long-Standing Korean Type 2 Diabetes Mellitus Patients with Diabetic Retinopathy: A Study Based on Standardized Clinical Data.

本文引用的文献

1
The status of diabetes control in Asia--a cross-sectional survey of 24 317 patients with diabetes mellitus in 1998.亚洲糖尿病控制状况——1998年对24317例糖尿病患者的横断面调查
Diabet Med. 2002 Dec;19(12):978-85. doi: 10.1046/j.1464-5491.2002.00833.x.
2
The Diabcare-Asia 1998 study--outcomes on control and complications in type 1 and type 2 diabetic patients.1998年亚洲糖尿病护理研究——1型和2型糖尿病患者的控制情况及并发症结果
Curr Med Res Opin. 2002;18(5):317-27. doi: 10.1185/030079902125000822.
3
Standards of medical care for patients with diabetes mellitus.
基于标准化临床数据的长期韩国2型糖尿病视网膜病变患者特征研究
Diabetes Metab J. 2017 Oct;41(5):393-404. doi: 10.4093/dmj.2017.41.5.393.
4
DiabCare survey of diabetes management and complications in the Gulf countries.海湾国家糖尿病管理与并发症的DiabCare调查。
Indian J Endocrinol Metab. 2016 Mar-Apr;20(2):219-27. doi: 10.4103/2230-8210.176347.
5
Effects of diabetic case management on knowledge, self-management abilities, health behaviors, and health service utilization for diabetes in Korea.糖尿病病例管理对韩国糖尿病患者的知识、自我管理能力、健康行为及医疗服务利用情况的影响。
Yonsei Med J. 2015 Jan;56(1):244-52. doi: 10.3349/ymj.2015.56.1.244.
6
Therapeutic target achievement in type 2 diabetic patients after hyperglycemia, hypertension, dyslipidemia management.治疗目标在 2 型糖尿病患者高血糖、高血压、血脂异常管理后的实现。
Diabetes Metab J. 2011 Jun;35(3):264-72. doi: 10.4093/dmj.2011.35.3.264. Epub 2011 Jun 30.
7
The Correlation and Accuracy of Glucose Levels between Interstitial Fluid and Venous Plasma by Continuous Glucose Monitoring System.连续血糖监测系统检测组织间液与静脉血浆葡萄糖水平的相关性及准确性
Korean Diabetes J. 2010 Dec;34(6):350-8. doi: 10.4093/kdj.2010.34.6.350. Epub 2010 Dec 31.
8
Clinical experience of an iontophoresis based glucose measuring system.基于离子电渗疗法的葡萄糖测量系统的临床经验
J Korean Med Sci. 2007 Feb;22(1):70-3. doi: 10.3346/jkms.2007.22.1.70.
糖尿病患者的医疗护理标准。
Diabetes Care. 2002 Jan;25(1):213-29. doi: 10.2337/diacare.25.1.213.
4
Health care and health status and outcomes for patients with type 2 diabetes.2型糖尿病患者的医疗保健、健康状况及预后
Diabetes Care. 2000 Jun;23(6):754-8. doi: 10.2337/diacare.23.6.754.
5
The epidemiology of diabetes mellitus in the Asia-Pacific region.亚太地区糖尿病的流行病学
Hong Kong Med J. 2000 Mar;6(1):43-52.
6
A desktop guide to Type 2 diabetes mellitus. European Diabetes Policy Group 1999.2型糖尿病桌面指南。欧洲糖尿病政策组,1999年。
Diabet Med. 1999 Sep;16(9):716-30.
7
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.二甲双胍强化血糖控制对超重2型糖尿病患者并发症的影响(英国前瞻性糖尿病研究34)。英国前瞻性糖尿病研究(UKPDS)小组。
Lancet. 1998 Sep 12;352(9131):854-65.
8
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.磺脲类或胰岛素强化血糖控制与传统治疗及2型糖尿病患者并发症风险的比较(英国前瞻性糖尿病研究[UKPDS 33])。英国前瞻性糖尿病研究(UKPDS)小组
Lancet. 1998 Sep 12;352(9131):837-53.
9
Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.1995 - 2025年全球糖尿病负担:患病率、数值估计及预测
Diabetes Care. 1998 Sep;21(9):1414-31. doi: 10.2337/diacare.21.9.1414.
10
The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT).糖尿病控制与并发症试验(DCCT)中强化糖尿病治疗对自主神经系统功能指标的影响。
Diabetologia. 1998 Apr;41(4):416-23. doi: 10.1007/s001250050924.